CIK: 0001595851 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 14, 2017
Total Value: $471M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUST | 350,000 | $30.3M | 6.4% | $86.57 | — | — | Put | 78464A870 |
| — | IMMUNOMEDICS INC | 1,946,946 | $27.22M | 5.8% | $13.98 | $7.08 | — | COM | 452907108 |
| — | ZOGENIX INC | 650,000 | $22.78M | 4.8% | $35.05 | $31.08 | — | Put | 98978L204 |
| — | ZOGENIX INC | 600,000 | $21.03M | 4.5% | $35.05 | $31.08 | — | COM NEW | 98978L204 |
| — | AVEXIS INC | 200,000 | $19.35M | 4.1% | $96.73 | $49.54 | — | Put | 05366U100 |
| — | DBV TECHNOLOGIES S A | 420,886 | $17.86M | 3.8% | $42.44 | $35.76 | — | SPONSORED ADR | 23306J101 |
| — | DBV TECHNOLOGIES S A | 403,500 | $17.13M | 3.6% | $42.44 | $35.76 | — | Put | 23306J101 |
| — | ALEXION PHARMACEUTICALS INC | 100,000 | $14.03M | 3.0% | $140.29 | $121.67 | — | COM | 015351109 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 225,000 | $13.79M | 2.9% | $61.28 * | $46.15 | +14.3% | COM | 64125C109 |
| — | ACCELERON PHARMA INC | 350,000 | $13.06M | 2.8% | $37.32 | $34.51 | — | COM | 00434H108 |
| — | NEVRO CORP | 115,000 | $10.45M | 2.2% | $90.88 | $74.43 | — | COM | 64157F103 |
| — | ENTELLUS MED INC | 561,510 | $10.37M | 2.2% | $18.46 | $17.22 | — | COM | 29363K105 |
| INSM | INSMED INC | 324,400 | $10.13M | 2.2% | $31.21 * | $17.08 | +11.5% | COM PAR $.01 | 457669307 |
| — | AVEXIS INC | 104,539 | $10.11M | 2.1% | $96.73 | $49.54 | — | COM | 05366U100 |
| BMY | BRISTOL MYERS SQUIBB CO | 150,000 | $9.561M | 2.0% | $63.74 * | $43.12 | 0.0% | Call | 110122108 |
| TMO | THERMO FISHER SCIENTIFIC INC | 50,000 | $9.46M | 2.0% | $189.20 * | $177.07 | 0.0% | COM | 883556102 |
| INSM | INSMED INC | 300,000 | $9.363M | 2.0% | $31.21 * | $17.08 | +11.5% | Call | 457669307 |
| — | SAGE THERAPEUTICS INC | 150,000 | $9.345M | 2.0% | $62.30 | $46.68 | — | Put | 78667J108 |
| — | GENMARK DIAGNOSTICS INC | 950,000 | $9.149M | 1.9% | $9.63 | $12.22 | — | COM | 372309104 |
| ZBH | ZIMMER BIOMET HLDGS INC | 75,000 | $8.782M | 1.9% | $117.09 * | $113.85 | -5.3% | COM | 98956P102 |
| BSX | BOSTON SCIENTIFIC CORP | 275,000 | $8.022M | 1.7% | $29.17 * | $22.19 | +24.5% | COM | 101137107 |
| PBYI | PUMA BIOTECHNOLOGY INC | 65,000 | $7.784M | 1.7% | $119.75 * | $36.49 | +154.9% | COM | 74587V107 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 250,000 | $7.763M | 1.6% | $31.05 | $31.05 | — | COM | 37890U108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 50,000 | $7.602M | 1.6% | $152.04 | $150.51 | 0.0% | COM | 92532F100 |
| ASND | ASCENDIS PHARMA A S | 200,000 | $7.25M | 1.5% | $36.25 | $36.25 | — | SPONSORED ADR | 04351P101 |
| — | SPARK THERAPEUTICS INC | 80,000 | $7.133M | 1.5% | $89.16 | $72.89 | — | COM | 84652J103 |
| IRTC | IRHYTHM TECHNOLOGIES INC | 135,000 | $7.004M | 1.5% | $51.88 * | $36.42 | +24.3% | COM | 450056106 |
| — | IGNYTA INC | 550,000 | $6.793M | 1.4% | $12.35 | $12.35 | — | COM | 451731103 |
| — | PATTERSON COMPANIES INC | 160,000 | $6.184M | 1.3% | $38.65 | $38.65 | — | COM | 703395103 |
| — | INTERCEPT PHARMACEUTICALS IN | 100,000 | $5.804M | 1.2% | $58.04 | $58.03 | — | Call | 45845P108 |
| ARGX | ARGENX SE | 252,534 | $5.71M | 1.2% | $22.61 | $21.52 | — | SPONSORED ADR | 04016X101 |
| — | AQUINOX PHARMACEUTICALS INC | 400,000 | $5.676M | 1.2% | $14.19 | $13.70 | — | COM | 03842B101 |
| — | NANOSTRING TECHNOLOGIES INC | 345,284 | $5.58M | 1.2% | $16.16 | $17.11 | — | COM | 63009R109 |
| — | GW PHARMACEUTICALS PLC | 50,000 | $5.075M | 1.1% | $101.50 | $100.25 | — | ADS | 36197T103 |
| — | AIMMUNE THERAPEUTICS INC | 200,000 | $4.958M | 1.1% | $24.79 | $20.56 | — | COM | 00900T107 |
| BMY | BRISTOL MYERS SQUIBB CO | 75,000 | $4.781M | 1.0% | $63.75 * | $43.12 | 0.0% | COM | 110122108 |
| SRPT | SAREPTA THERAPEUTICS INC | 100,000 | $4.536M | 1.0% | $45.36 * | $39.97 | 0.0% | COM | 803607100 |
| — | JUNO THERAPEUTICS INC | 100,000 | $4.486M | 1.0% | $44.86 | $29.89 | — | COM | 48205A109 |
| MRK | MERCK & CO INC | 65,000 | $4.162M | 0.9% | $64.03 * | $46.68 | 0.0% | COM | 58933Y105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 35,000 | $4.112M | 0.9% | $117.49 * | $85.36 | 0.0% | COM | 02043Q107 |
| ACAD | ACADIA PHARMACEUTICALS INC | 109,000 | $4.106M | 0.9% | $37.67 * | $34.90 | -6.8% | Call | 004225108 |
| INCY | INCYTE CORP | 35,000 | $4.086M | 0.9% | $116.74 * | $126.52 | 0.0% | COM | 45337C102 |
| VRAYQ | VIEWRAY INC | 700,000 | $4.032M | 0.9% | $5.76 * | $6.69 | -15.8% | COM | 92672L107 |
| — | CURRENCYSHS BRIT POUND STER | 30,100 | $3.923M | 0.8% | $130.33 | $126.82 | — | BRIT POUND STE | 23129S106 |
| — | AIMMUNE THERAPEUTICS INC | 150,000 | $3.719M | 0.8% | $24.79 | $20.56 | — | Call | 00900T107 |
| — | NEOS THERAPEUTICS INC | 400,000 | $3.66M | 0.8% | $9.15 | $7.30 | — | COM | 64052L106 |
| — | AERIE PHARMACEUTICALS INC | 75,000 | $3.645M | 0.8% | $48.60 | $48.60 | — | COM | 00771V108 |
| — | RA PHARMACEUTICALS INC | 235,000 | $3.431M | 0.7% | $14.60 | $16.47 | — | COM | 74933V108 |
| FOLD | AMICUS THERAPEUTICS INC | 200,000 | $3.016M | 0.6% | $15.08 * | $13.23 | 0.0% | COM | 03152W109 |
| — | KADMON HLDGS INC | 850,000 | $2.848M | 0.6% | $3.35 | $3.35 | — | COM | 48283N106 |
| — | RIGEL PHARMACEUTICALS INC | 1,100,000 | $2.794M | 0.6% | $2.54 | $2.62 | — | COM NEW | 766559603 |
| BCRX | BIOCRYST PHARMACEUTICALS | 500,000 | $2.62M | 0.6% | $5.24 * | $4.04 | +26.7% | COM | 09058V103 |
| — | INTERCEPT PHARMACEUTICALS IN | 35,000 | $2.031M | 0.4% | $58.03 | $58.03 | — | COM | 45845P108 |
| PTCT | PTC THERAPEUTICS INC | 100,000 | $2.001M | 0.4% | $20.01 * | $12.10 | +61.5% | COM | 69366J200 |
| PTCT | PTC THERAPEUTICS INC | 100,000 | $2.001M | 0.4% | $20.01 * | $12.10 | +61.5% | Call | 69366J200 |
| IRIX | IRIDEX CORP | 199,519 | $1.869M | 0.4% | $9.37 * | $14.17 | -35.8% | COM | 462684101 |
| — | NUVASIVE INC | 30,000 | $1.664M | 0.4% | $55.47 | $57.34 | — | COM | 670704105 |
| EXEL | EXELIXIS INC | 53,500 | $1.296M | 0.3% | $24.22 * | $26.62 | 0.0% | COM | 30161Q104 |
| — | DECIPHERA PHARMACEUTICALS IN | 64,410 | $1.223M | 0.3% | $18.99 | $18.99 | — | COM | 24344T101 |
| — | NABRIVA THERAPEUTICS PLC | 120,000 | $983K | 0.2% | $8.19 | $8.19 | — | SHS | G63637105 |
| — | QUOTIENT LTD | 187,450 | $924K | 0.2% | $4.93 | $7.36 | — | SHS | G73268107 |
| — | AXOVANT SCIENCES LTD | 100,000 | $688K | 0.1% | $6.88 | $23.19 | — | COM | G0750W104 |
| — | VERSARTIS INC | 275,000 | $674K | 0.1% | $2.45 | $2.45 | — | COM | 92529L102 |